COMMUNIQUÉS West-GlobeNewswire

AIT Therapeutics Reports Financial Results for First Fiscal Quarter 2019
14/08/2018
Started commercial development of ventilator compatible NO generator and delivery system -- FDA 510(k) submission expected in the first quarter of calendar 2019 Human and in-vitro Nitric Oxide (NO) data presented at the [...]
Progressive Care Inc. Reports Largest Six-Month Revenue Period in Company History in Q2 2018 Financial Filing
14/08/2018
MIAMI, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced financial results for the quarter ending June 30, 2018, and [...]
Kane Biotech Achieves DTC Eligibility in the United States
14/08/2018
WINNIPEG, Manitoba, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce that the Corporation has secured eligibility by The [...]
CrownBio Expands Genetically Engineered Model Selection Via Strategic Alliance with Shanghai Model Organisms Center (SMOC)
14/08/2018
Alliance enables researchers to access thousands of GEMMs SAN DIEGO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to [...]
Micron Solutions, Inc. Reports 2018 Second Quarter Results
14/08/2018
FITCHBURG, Mass., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American:MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, [...]
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
14/08/2018
NORTHVALE, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]
Avenue Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
14/08/2018
Company reported positive Phase 3 data in patients with post-surgical pain following bunionectomy Initiation of second pivotal Phase 3 trial expected in the second half of 2018 NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE [...]
Iterum Reports Second Quarter 2018 Financial Results and Recent Highlights
14/08/2018
DUBLIN, Ireland and CHICAGO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company developing anti-infectives against multi-drug resistant pathogens, today [...]
Cancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business Updates
14/08/2018
Conference call at 8:30 a.m. ET, Tuesday, August 14, 2018 RUTHERFORD, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic [...]
Stemline Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference
14/08/2018
NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today that Ivan Bergstein, M.D., [...]
Nephros Subsidiary Specialty Renal Products and HemoCleanse Announce License Agreement for Dialysate Filtration System
14/08/2018
Pioneering HemoCleanse CEO to Join Specialty Renal Products Board of Directors SOUTH ORANGE, NJ, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Specialty Renal Products, Inc. (SRP), a subsidiary of Nephros, Inc. (OTCQB:NEPH), a [...]
Avalon GloboCare Appoints Dr. James L. Gajewski, Former Medical Director at M.D. Anderson Cancer Center, to Head Scientific and Clinical Advisory Board
14/08/2018
FREEHOLD, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that the Company has appointed James L. Gajewski, M.D., M.A. [...]
Transactions in relation to share buyback program
14/08/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Optinose Reports Second Quarter 2018 Financial Results and Recent Operational Highlights
14/08/2018
Company reports second quarter net product sales of $1.3 million and that more than 2,600 physicians have prescribed XHANCE since launch Conference call and webcast to be held today at 8:00 a.m. Eastern Time YARDLEY, Pa [...]
Establishment Labs Reports Second Quarter 2018 Financial Results
14/08/2018
NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics [...]
Microbix Reports Record Third Quarter Sales
14/08/2018
Year-Over-Year Sales Growth of 24% in First Nine Months TORONTO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports financial [...]
UroGen Pharma Reports Second Quarter 2018 Financial Results and Recent Corporate Developments
14/08/2018
Plan to Initiate Q4 2018 Rolling New Drug Application (NDA) Submission to the U.S. Food and Drug Administration (FDA) for UGN-101, Ahead of Initial Projection of Q1 2019 Initiated Phase 2b Clinical Trial of UGN-102 ( [...]
Auxly Announces Product Strategy Update and World-Class Additions to Dosecann's Management Team
14/08/2018
VANCOUVER, British Columbia, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to provide an update on the product strategy of the Company’s wholly owned [...]
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2018
14/08/2018
Second Product Program, NZV930 Enters Clinical Development CAMBRIDGE, Mass., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation [...]

Pages